WallStreetZenWallStreetZen

NASDAQ: EIKN
Eikon Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Eikon Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EIKN annual revenue was $0.0, with N/A growth year-over-year.

EIKN revenue history

Current Revenue
$0.0
Current Earnings
-$333.6M
Current Profit Margin
0%

Be the first to know when EIKN announces revenue.

EIKN Revenue History By Year

EIKN Yearly RevenueEIKN RevenueEIKN ChangeEIKN Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A

1 of 1

Eikon Therapeutics Revenue FAQ

What was EIKN's revenue last quarter?

Eikon Therapeutics (NASDAQ: EIKN) reported Q4 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Eikon Therapeutics's revenue was $0.00.

What was Eikon Therapeutics's revenue in 2025?

Eikon Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Eikon Therapeutics make in a day?

Based on Eikon Therapeutics annual revenue for the past two years, EIKN makes an average of $0.00 per day.

What was Eikon Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Eikon Therapeutics's revenue has grown null year over year. Eikon Therapeutics's revenue in the past year totaled $0.00.

How much does Eikon Therapeutics make in a year?

Eikon Therapeutics's revenue by year for the past two years is:
  • Eikon Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
  • Eikon Therapeutics's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.